You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GSK PLC - ADR

GSK Plc - ADR XNYS: GSK

GSK Plc - ADR Live Share Price Today, Share Analysis and Chart

Await Turnaround
Download real time

35.93 0.56 (1.58%)

4.6M XNYS Volume

XNYS 17 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for GSK Plc - ADR is on 01 May 2025 for the purpose of GSK PLC First Quarter Earnings Result for 2025 See details

GSK Plc - ADR Key Metrics

Default

Market Capitalization

High in industry
72,793.3

PE TTM

High in industry
21.3

PEG TTM

Negative PEG TTM
-0.4

Price to Book

Below industry Median
3.1

Institutional holding current Qtr %

Below industry Median
16.5

Revenue Growth Qtr YoY %

Below industry Median
0.8

Operating Revenue growth TTM %

Below industry Median
3.5

Net Profit Qtr Growth YoY %

Below industry Median
18.3

Net Profit TTM Growth %

Negative Net Profit TTM Growth %
-47.7

Operating Profit Margin Qtr %

High in industry
27.3

Operating Profit Margin TTM %

High in industry
17.7

Piotroski Score

High in industry
3

Rel Perf vs Sector quarter%

8.4

ROE Annual %

High in industry
19.1

RoA Annual %

High in industry
4.3
All financials are in GBP Million and price data in USD
VIEW MORE
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Mid Valuation
30.2 / 100
Momentum Score
Technically Neutral
38.1 / 100
Await Turnaround These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks. View Similar Embed DVM
Analyst Price Target
43
1Yr Price target upside is 19%
9 analysts

GSK Plc - ADR Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '2630k40k50k35k45kActual RevenueAvg. Estimate
Hit

GSK Plc - ADR's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

Current EPS
1.6
Avg. Estimate
3.5
Low Estimate
3.5
High Estimate
3.5
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 127.7% in FY25

Consensus Recommendation

9 ANALYST Recommendations
HOLD

Created with Highcharts 7.2.21Strong Sell1Sell4Hold1Buy2Strong Buy

The consensus recommendation from 9 analysts for GSK Plc - ADR is HOLD

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

GSK Plc - ADR Stock Analysis

GSK Plc - ADR stock analysis with key metrics, changes, and trends.

GSK Plc - ADR MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$31,376 M3.46%positive

Annual Revenue rose 3.46%, in the last year to $31,376 M. Its sector's average revenue growth for the last fiscal year was 7.54%.

Annual Net Profit$2,575 M47.75%negative

Annual Net Profit fell 47.75% in the last year to $2,575 M. Its sector's average net profit growth for the last fiscal year was -30.36%.

Price to Earning Ratio21.26-negative

Price to Earning Ratio is 21.26, higher than its sector PE ratio of 3.22.

Stock Price$35.93-9.61%negative

Stock Price fell 9.61% and underperformed its sector by 16.94% in the past year.

Quarterly Revenue$8,117 M0.81%positive

Quarterly Revenue rose 0.81% YoY to $8,117 M. Its sector's average revenue growth YoY for the quarter was 5.84%.

Quarterly Net profit$414 M18.29%positive

Quarterly Net profit rose 18.29% YoY to $414 M. Its sector's average net profit growth YoY for the quarter was -48.37%.

Debt to Equity Ratio1.24-negative

Debt to Equity Ratio of 1.24 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE)19.06 %19.06%neutral

Return on Equity(ROE) for the last financial year was 19.06%, in the normal range of 10% to 20%.

Mutual Fund Holding8.33 %0.19%positive

Mutual Fund Holding increased by 0.19% in the last quarter to 8.33.

Interest Coverage Ratio6.43-positive

Interest Coverage Ratio is 6.43, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding16.52 %-0.22%negative

Institutional Holding decreased by 0.22% in the last quarter to 16.52.

VIEW LESS


Loading data..

GSK Plc - ADR - Company Profile

What does GSK Plc - ADR do?

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK Plc - ADR Management structure

All Gross Remunerations are in GBP
Dame Emma N. Walmsley
Executive Director, Chief Executive Officer
10.56 M
2024
Gross Remuneration
Year
Ms. Julie Brown
Executive Director, Chief Financial Officer
4.17 M
2024
Gross Remuneration
Year
Mrs. Victoria Anne Whyte
Company Secretary
-
2024
Gross Remuneration
Year

GSK Plc - ADR Board of directors

All Gross Remunerations are in GBP
Sir Jonathan Richard Symonds CBE
Non-Executive Director, Chairman
781 K
2024
Gross Remuneration
Year
Dr. Hal V Barron
Non-Executive Director
462 K
2024
Gross Remuneration
Year
Mr. Charles A. Bancroft
Non-Executive Director, Senior Independent Director
333 K
2024
Gross Remuneration
Year
Dr. Harry C Dietz
Non-Executive Director
275 K
2024
Gross Remuneration
Year
Dr. Anne Beal
Non-Executive Director
255 K
2024
Gross Remuneration
Year
Dr. Jesse Goodman, M.D.,M.P.H.
Non-Executive Director
228 K
2024
Gross Remuneration
Year

GSK Plc - ADR FAQ

How is GSK Plc - ADR today?
GSK Plc - ADR today is trading in the green, and is up by 1.58% at 35.93.
GSK Plc - ADR is currently trading up 1.58% on an intraday basis. In the past week the stock rose 3.72%. stock has been up 7.48% in the past quarter and fell -9.61% in the past year. You can view this in the overview section.